Literature DB >> 8425658

Can we really predict IDDM?

P J Bingley1, E Bonifacio, E A Gale.   

Abstract

Risk of progression to IDDM has been assessed extensively in first-degree relatives of IDDM patients, and highly specific prediction is possible within a small subset of this population. Because approximately 90% of future cases will come from those who have no close relative with IDDM, prediction and intervention within the general population will become the main priority for the future. This review presents a decision tree analysis of risk of progression to IDDM, highlights the different prognosis of markers when applied to those with and without a family history of the disease, and proposes a strategy for disease prediction in the latter. Large collaborative studies in well-characterized populations will allow new predictive markers and models to be evaluated, and strategies of intervention to be tested with maximum efficiency and minimal delay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425658     DOI: 10.2337/diab.42.2.213

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

Review 1.  T-cell reactivity to beta-cell antigens in human insulin-dependent (type 1) diabetes mellitus. Implications for diagnosis and therapy.

Authors:  B O Roep
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

Review 3.  Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal.

Authors:  B O Roep; M Atkinson
Journal:  Diabetologia       Date:  2004-10-13       Impact factor: 10.122

Review 4.  Advances in childhood onset diabetes.

Authors:  J P Shield; J D Baum
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

5.  The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.

Authors:  Stef J Bloem; Bart O Roep
Journal:  Diabetologia       Date:  2017-04-24       Impact factor: 10.122

6.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

7.  Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.

Authors:  D Schatz; J Krischer; G Horne; W Riley; R Spillar; J Silverstein; W Winter; A Muir; D Derovanesian; S Shah
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.

Authors:  Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

9.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

Review 10.  Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.

Authors:  Jakob Appel Østergaard; Esben Laugesen; R David Leslie
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.